From: Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
Beta | Std. Error | p value | OR | 2.5% | 97.5% | |
---|---|---|---|---|---|---|
Intercept | 1.170 | 2.754 | 0.671 | 3.222 | 0.016 | 945 |
Sex | − 0.133 | 0.962 | 0.889 | 0.875 | 0.113 | 5.503 |
Hospital Stay | 0.416 | 0.164 | 0.011 | 0.659 | 0.455 | 0.872 |
Thrombolysis | 2.317 | 1.001 | 0.020 | 10.148 | 1.604 | 90.102 |
NIHSS-basal | − 0.134 | 0.112 | 0.233 | 0.874 | 0.677 | 1.065 |
Diabetes | 1.518 | 1.028 | 0.139 | 4.566 | 0.658 | 1.065 |
HDL | 0.009 | 0.044 | 0.831 | 1.010 | 0.924 | 1.105 |
LDL | 0.009 | 0.008 | 0.249 | 1.010 | 0.993 | 1.027 |
Tryglicerides | − 0.001 | 0.003 | 0.941 | 1.000 | 0.991 | 1.007 |
RR | − 1.538 | 1.095 | 0.160 | 0.215 | 0.021 | 1.628 |
Risks | − 0.458 | 0.497 | 0.356 | 0.633 | 0.218 | 1.593 |
TLM | − 0.022 | 0.018 | 0.222 | 0.977 | 0.936 | 1.011 |